# Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

Study · id `cardio:ct-nct07246629` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07246629](<https://clinicaltrials.gov/study/NCT07246629>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07246629

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 214 participants.

## Technical summary

Registry record NCT07246629. Randomized; triple masking; primary purpose prevention. Start 2027-01 (anticipated); primary completion 2028-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 214 participants (planned count; ClinicalTrials.gov record NCT07246629, source copy `cardio:ctgov-nct07246629-2026-10-01`, retrieved 2026-10-31)
- Planned start: 2027-01 (anticipated) (ClinicalTrials.gov record NCT07246629, source copy `cardio:ctgov-nct07246629-2026-10-01`, retrieved 2026-10-31)
- Primary completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT07246629, source copy `cardio:ctgov-nct07246629-2026-10-01`, retrieved 2026-10-31)
- Completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT07246629, source copy `cardio:ctgov-nct07246629-2026-10-01`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT07246629, source copy `cardio:ctgov-nct07246629-2026-10-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07246629-2026-10-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
- Condition: Subarachnoid Hemorrhage
- Intervention (Drug): Normal Saline
- Intervention (Drug): Nicardipine
- Lead sponsor: Wake Forest University Health Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: Wake Forest University Health Sciences (`cardio:wake-forest-health-sciences`)

## Provenance

Content hash: 58a63447fac794f97281a0faec01e45ef2faa81377026e679deb3cc03494c645
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
